...
机译:循环β细胞特异性CD8 + + + T细胞受高风险HLA类I分子的限制,患儿童患有1型糖尿病的抗原经验
Department of ImmunobiologyKing’s College LondonLondon UK;
Department of ImmunobiologyKing’s College LondonLondon UK;
National Institute of Health Research Biomedical Research Centre at Guy’s and St Thomas’ Hospital;
Department of ImmunobiologyKing’s College LondonLondon UK;
Department of ImmunobiologyKing’s College LondonLondon UK;
National Institute of Health Research Biomedical Research Centre at Guy’s and St Thomas’ Hospital;
Division of Infection and ImmunityCardiff UniversityCardiff UK;
Division of Infection and ImmunityCardiff UniversityCardiff UK;
Research Program for Clinical and Molecular MetabolismUniversity of HelsinkiHelsinki Finland;
Immunogenetics LaboratoryUniversity of TurkuTurku Finland;
Department of PaediatricsUniversity of Turku and Turku University HospitalTurku Finland;
Department of PaediatricsOulu University Hospital and University of OuluOulu Finland;
Research Program for Clinical and Molecular MetabolismUniversity of HelsinkiHelsinki Finland;
Immunogenetics LaboratoryUniversity of TurkuTurku Finland;
Department of ImmunobiologyKing’s College LondonLondon UK;
CD8 + T cells; HLA‐B*39; HLA‐A*24; type 1 diabetes;
机译:循环β细胞特异性CD8 + + + T细胞受高风险HLA类I分子的限制,患儿童患有1型糖尿病的抗原经验
机译:肿瘤抗原脉冲自体树突状细胞体外诱导患有局部晚期乳腺癌的患者的肿瘤特异性HLA I类限制性CD8 +细胞毒性T淋巴细胞。
机译:靶向克隆受特定HLA I类分子限制的次要组织相容性抗原的细胞毒性T细胞。
机译:识别预测的H1V-1 GAG B * 3501 - 用HLA-B * 3501〜+患者识别预测的H1V-1 GAG B * 3501的方法:通过定量ELISPOT分析和使用多数量的确认
机译:提供抗原特异性CD4 + T细胞可防止在前列腺癌的小鼠模型中耐受CD8 +肿瘤特异性T细胞。
机译:受高风险HLA I类分子限制的循环中的β细胞特异性CD8 + T细胞在患有1型糖尿病并有风险的儿童中显示出抗原经历
机译:循环受高风险HLA类分子限制的β细胞特异性CD8 + T细胞显示出患有1型糖尿病的儿童的抗原经验